CVS Health Co. (NYSE:CVS) Shares Sold by Money Concepts Capital Corp

Money Concepts Capital Corp decreased its holdings in shares of CVS Health Co. (NYSE:CVS) by 12.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,192 shares of the pharmacy operator’s stock after selling 848 shares during the period. Money Concepts Capital Corp’s holdings in CVS Health were worth $278,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CVS. AMF Tjanstepension AB increased its position in CVS Health by 124.1% during the 3rd quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock worth $3,882,000 after purchasing an additional 34,198 shares during the period. Czech National Bank boosted its stake in shares of CVS Health by 7.2% during the 3rd quarter. Czech National Bank now owns 256,430 shares of the pharmacy operator’s stock worth $16,124,000 after acquiring an additional 17,206 shares in the last quarter. Brookstone Capital Management boosted its stake in shares of CVS Health by 4.6% during the 3rd quarter. Brookstone Capital Management now owns 62,589 shares of the pharmacy operator’s stock worth $3,936,000 after acquiring an additional 2,764 shares in the last quarter. CWM LLC boosted its stake in shares of CVS Health by 14.1% during the 3rd quarter. CWM LLC now owns 76,241 shares of the pharmacy operator’s stock worth $4,794,000 after acquiring an additional 9,435 shares in the last quarter. Finally, Hexagon Capital Partners LLC boosted its stake in shares of CVS Health by 3.5% during the 3rd quarter. Hexagon Capital Partners LLC now owns 5,268 shares of the pharmacy operator’s stock worth $331,000 after acquiring an additional 178 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Evercore ISI boosted their price target on CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research note on Monday, January 27th. Wells Fargo & Company raised CVS Health from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. Truist Financial decreased their price target on CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Edward Jones raised CVS Health from a “hold” rating to a “buy” rating in a research note on Thursday, January 30th. Finally, Royal Bank of Canada reduced their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research note on Friday, November 15th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $68.12.

CVS Health Trading Down 2.7 %

Shares of CVS Health stock opened at $54.20 on Friday. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $80.75. The firm has a market cap of $68.21 billion, a PE ratio of 13.76, a P/E/G ratio of 0.62 and a beta of 0.61. The business’s fifty day moving average is $51.02 and its two-hundred day moving average is $56.04. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the prior year, the firm posted $2.21 EPS. Analysts anticipate that CVS Health Co. will post 5.14 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were issued a dividend of $0.665 per share. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.91%. CVS Health’s payout ratio is 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.